Dong-A second challenge on global new drug, having similar figure as Sivextro
The second new global drug developed by Dong-A ST is expected to take a momentum to launch soon. The interesting point is that it has taken a very similar walk as the story of the super antibiotic Sivextro.
According to foreign press, Allergan famous for the botulinum agent Botox announced acqu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
